Earlier this month, the U.S. District Court for the Middle District of Alabama decided Method Pharmaceuticals, LLC v. H-2 Pharma, LLC, a dispute concerning labeling for fluoride.
An Alabama federal judge won't let H-2 Pharma LLC escape a suit from a competitor alleging it misleads consumers into thinking its fluoride products are prescription drugs, finding that only one of the five claims in the suit is blocked by federal law.